脂肪组织
脂联素
脂肪因子
医学
内科学
微循环
胰岛素抵抗
内分泌学
旁分泌信号
脂肪细胞
肥胖
糖尿病
受体
作者
Claudia Agabiti Rosei,Sophie N. Saxton,Carolina De Ciuceis,María Lorenza Muiesan,Damiano Rizzoni,Enrico Agabiti Rosei,Anthony M. Heagerty
出处
期刊:Hypertension
[Ovid Technologies (Wolters Kluwer)]
日期:2023-11-08
卷期号:81 (1): 24-33
被引量:4
标识
DOI:10.1161/hypertensionaha.123.19437
摘要
Alterations in microcirculation play a crucial role in the pathogenesis of cardiovascular and metabolic disorders such as obesity and hypertension. The small resistance arteries of these patients show a typical remodeling, as indicated by an increase of media or total wall thickness to lumen diameter ratio that impairs organ flow reserve. The majority of blood vessels are surrounded by a fat depot which is termed perivascular adipose tissue (PVAT). In recent years, data from several studies have indicated that PVAT is an endocrine organ that can produce a variety of adipokines and cytokines, which may participate in the regulation of vascular tone, and the secretory profile varies with adipocyte phenotype and disease status. The PVAT of lean humans largely secretes the vasodilator adiponectin, which will act in a paracrine fashion to reduce peripheral resistance and improve nutrient uptake into tissues, thereby protecting against the development of hypertension and diabetes. In obesity, PVAT becomes enlarged and inflamed, and the bioavailability of adiponectin is reduced. The inevitable consequence is a rise in peripheral resistance with higher blood pressure. The interrelationship between obesity and hypertension could be explained, at least in part, by a cross-talk between microcirculation and PVAT. In this article, we propose an integrated pathophysiological approach of this relationship, in order to better clarify its role in obesity and hypertension, as the basis for effective and specific prevention and treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI